Variation in the vascular endothelial growth factor gene, carotid intima‐media thickness and the risk of acute myocardial infarction

References

• Ferrara N., Gerber H. P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669–76
   PubMed Web of Science ®Google Scholar
• Roy H., Bhardwaj S., Ylä‐Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006; 580: 2879–87
   PubMed Web of Science ®Google Scholar
• Roy H., Bhardwaj S., Babu M., Kokina I., Uotila S., Ahtialansaari T., Laitinen T., Hakumaki J., Laakso M., Herzig K. H., Ylä‐Herttuala S. VEGF‐A, VEGF‐D, VEGF receptor‐1, VEGF receptor‐2, NF‐kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits. FASEB J 2006; 20: 2159–61
   PubMed Web of Science ®Google Scholar
• Celletti F. L., Waugh J. M., Amabile P. G., Brendolan A., Hilfiker P. R., Dake M. D. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001; 7: 425–9
   PubMed Web of Science ®Google Scholar
• Bhardwaj S., Roy H., Heikura T., Ylä‐Herttuala S. VEGF‐A, VEGF‐D and VEGF‐D(DeltaNDeltaC) induced intimal hyperplasia in carotid arteries. Eur J Clin Invest 2005; 35: 669–76
   PubMed Web of Science ®Google Scholar
• Moreno P. R., Purushothaman K. R., Fuster V., Echeverri D., Truszczynska H., Sharma S. K., Badimon J. J., O'Connor W. N. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 2004; 110: 2032–8
   PubMed Web of Science ®Google Scholar
• Morsi W. G., Shaker O. G., Ismail E. F., Ahmed H. H., El‐Serafi T. I., Maklady F. A., bdel‐Aziz M. T., El‐Asmar M. F., Atta H. M. HO‐1 and VGEF gene expression in human arteries with advanced atherosclerosis. Clin Biochem 2006; 39: 1057–62
   PubMed Web of Science ®Google Scholar
• Leppänen P., Koota S., Kholova I., Koponen J., Fieber C., Eriksson U., Alitalo K., Ylä‐Herttuala S. Gene transfers of vascular endothelial growth factor‐A, vascular endothelial growth factor‐B, vascular endothelial growth factor‐C, and vascular endothelial growth factor‐D have no effects on atherosclerosis in hypercholesterolemic low‐density lipoprotein‐receptor/apolipoprotein B48‐deficient mice. Circulation 2005; 112: 1347–52
   PubMed Web of Science ®Google Scholar
• Gyongyosi M., Khorsand A., Zamini S., Sperker W., Strehblow C., Kastrup J., Jorgensen E., Hesse B., Tagil K., Botker H. E., Ruzyllo W., Teresinska A., Dudek D., Hubalewska A., Ruck A., Nielsen S. S., Graf S., Mundigler G., Novak J., Sochor H., Maurer G., Glogar D., Sylven C. NOGA‐guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A‐165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT‐ONE multicenter double‐blind randomized study. Circulation 2005; 112: I157–65
   PubMed Web of Science ®Google Scholar
• Reilly J. P., Grise M. A., Fortuin F. D., Vale P. R., Schaer G. L., Lopez J., Van C., Jr., Henry T., Richenbacher W. E., Losordo D. W., Schatz R. A., Isner J. M. Long‐term (2‐year) clinical events following transthoracic intramyocardial gene transfer of VEGF‐2 in no‐option patients. J Interv Cardiol 2005; 18: 27–31
   PubMedGoogle Scholar
• Alber H. F., Frick M., Dulak J., Dorler J., Zwick R. H., Dichtl W., Pachinger O., Weidinger F. Vascular endothelial growth factor (VEGF) plasma concentrations in coronary artery disease. Heart 2005; 91: 365–6
   PubMed Web of Science ®Google Scholar
• Shahbazi M., Fryer A. A., Pravica V., Brogan I. J., Ramsay H. M., Hutchinson I. V., Harden P. N. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002; 13: 260–4
   PubMed Web of Science ®Google Scholar
• Howell W. M., Ali S., Rose‐Zerilli M. J., Ye S. VEGF polymorphisms and severity of atherosclerosis. J Med Genet 2005; 42: 485–90
   PubMed Web of Science ®Google Scholar
• Awata T., Inoue K., Kurihara S., Ohkubo T., Watanabe M., Inukai K., Inoue I., Katayama S. A common polymorphism in the 5′‐untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002; 51: 1635–9
   PubMed Web of Science ®Google Scholar
• Krippl P., Langsenlehner U., Renner W., Yazdani‐Biuki B., Wolf G., Wascher T. C., Paulweber B., Haas J., Samonigg H. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003; 106: 468–71
   PubMed Web of Science ®Google Scholar
• Renner W., Kotschan S., Hoffmann C., Obermayer‐Pietsch B., Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000; 37: 443–8
   PubMed Web of Science ®Google Scholar
• Craven T. E., Ryu J. E., Espeland M. A., Kahl F. R., McKinney W. M., Toole J. F., McMahan M. R., Thompson C. J., Heiss G., Crouse JR I. I. I. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case‐control study. Circulation 1990; 82: 1230–42
   PubMed Web of Science ®Google Scholar
• van dM I., Bots M. L., Hofman A., del Sol A. I., van der Kuip D. A., Witteman J. C. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 2004; 109: 1089–94
   PubMed Web of Science ®Google Scholar
• Kauma H., Päivansalo M., Savolainen M. J., Rantala A. O., Kiema T. R., Lilja M., Reunanen A., Kesäniemi Y. A. Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis. J Hypertens 1996; 14: 1183–7
   PubMed Web of Science ®Google Scholar
• Tapanainen J. M., Still A. M., Airaksinen K. E., Huikuri H. V. Prognostic significance of risk stratifiers of mortality, including T wave alternans, after acute myocardial infarction: results of a prospective follow‐up study. J Cardiovasc Electrophysiol 2001; 12: 645–52
   PubMed Web of Science ®Google Scholar
• Wendelhag I., Gustavsson T., Suurkula M., Berglund G., Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 1991; 11: 565–77
   PubMedGoogle Scholar
• Tregouet D. A., Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 2007; 23: 1038–9
   PubMed Web of Science ®Google Scholar
• Gordon D., Finch S. J., Nothnagel M., Ott J. Power and sample size calculations for case‐control genetic association tests when errors are present: application to single nucleotide polymorphisms. Hum Hered 2002; 54: 22–33
   PubMed Web of Science ®Google Scholar
• Liao Y. C., Lin H. F., Rundek T., Cheng R., Guo Y. C., Sacco R. L., Juo S. H. Segment‐specific genetic effects on carotid intima‐media thickness. The Northern Manhattan Study. Stroke 2008; 39: 3159–65
   PubMed Web of Science ®Google Scholar
• Lambrechts D., Storkebaum E., Morimoto M., Del‐Favero J., Desmet F., Marklund S. L., Wyns S., Thijs V., Andersson J., van M. I., Al‐Chalabi A., Bornes S., Musson R., Hansen V., Beckman L., Adolfsson R., Pall H. S., Prats H., Vermeire S., Rutgeerts P., Katayama S., Awata T., Leigh N., Lang‐Lazdunski L., Dewerchin M., Shaw C., Moons L., Vlietinck R., Morrison K. E., Robberecht W., Van B. C., Collen D., Andersen P. M., Carmeliet P. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003; 34: 383–94
   PubMed Web of Science ®Google Scholar